AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion

Third of voters reject Pascal Soriot’s deal but some say it is deserved as he had been ‘massively underpaid’AstraZeneca has suffered a shareholder rebellion against an £18.7m pay packet for the pharmaceutical company’s chief executive, Pascal Soriot, with more than a third of votes cast opposing the deal.At its annual meeting in London 35.5% rejected the company’s remuneration policy, rising to 38.5% including withheld votes. In addition 34.7% voted against am